← Leaderboards
Eckhard R Podack
University Of Miami School Of Medicine
$11,788,352
Attributed
$11,788,352
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$19,976,256 · 15
By mechanism
P01$11,176,325 · 6
R01$5,181,013 · 4
R33$1,709,401 · 1
R21$1,525,767 · 3
R56$383,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Ryan Michael McCormack$267,802
- Thomas R Malek$20,207,638
Others in their field
Top investigators on “Natural Killer Cells”
- Barton F Haynes · Duke University$112,979,211
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Craig B Thompson · Sloan-Kettering Inst Can Research$42,638,329
- Selwyn M Vickers · University Of Alabama At Birmingham$41,029,054
- James C. Paulson · Scripps Research Institute$39,353,775
Research focus
Natural Killer CellsResponseCellsHeat Shock ProteinsMemoryNeoplastic CellImmunitySignal TransductionProteinsIn VivoVaccinesImmune ResponseCd8b1 GeneMolecularTumorMediatingLaboratory MouseGenerationsMacrophageAntigensBaseReceptorGenetically Modified AnimalsRegulation
Grant awards (48)
Killing of intracellular bacteria by Perforin-2$383,750
R01 · FY2015 · AI · contact PI
Mpeg1 in Innate Immunity$383,750
R56 · FY2014 · AI · contact PI
Mechanisms of mucosal protection by HPV-SIV and gp96-lg-SIV vaccines$2,000,000
P01 · FY2011 · AI · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$1,161,198
P01 · FY2011 · CA · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$446,977
R33 · FY2011 · AI · contact PI
Induction of Tumor Immunity by Secreted HSP-gp96$409,374
P01 · FY2011 · CA · contact PI
Response to and protection by gp96SIVIg/TNFSF13 and gp96SIVIg/TNFSF15 vaccines$371,695
P01 · FY2011 · AI · contact PI
Generation of gp96SIVIg/TNFSF13 and gp96SIVIg/TNFSF15 vaccinesVaccines$329,821
P01 · FY2011 · AI · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$25,681
P01 · FY2011 · CA · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$1,219,441
P01 · FY2010 · CA · contact PI
Induction of Tumor Immunity by Secreted HSP-gp96$454,604
P01 · FY2010 · CA · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$454,410
R33 · FY2010 · AI · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$42,298
P01 · FY2010 · CA · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$1,200,459
P01 · FY2009 · CA · contact PI
Induction of Tumor Immunity by Secreted HSP-gp96$464,423
P01 · FY2009 · CA · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$459,000
R33 · FY2009 · AI · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$349,014
R33 · FY2009 · AI · contact PI
Molecular Mechanisms of anti Tumor and anti Bacterial Cytotoxicity$222,845
R01 · FY2009 · CA · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$85,680
P01 · FY2009 · CA · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$1,169,175
P01 · FY2008 · CA · contact PI
Induction of Tumor Immunity by Secreted HSP-gp96$445,429
P01 · FY2008 · CA · contact PI
DR3 in Asthma and in Ontogeny$398,397
R01 · FY2008 · AI · contact PI
Molecular Mechanisms of anti Tumor and anti Bacterial Cytotoxicity$222,845
R01 · FY2008 · CA · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$186,019
R21 · FY2008 · AI · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$60,179
P01 · FY2008 · CA · contact PI
REGULATION OF ANTI-TUMOR IMMUNITY$1,223,793
P01 · FY2007 · CA · contact PI
Induction of Tumor Immunity by Secreted HSP-gp96$419,167
P01 · FY2007 · CA · contact PI
DR3 in Asthma and in Ontogeny$408,521
R01 · FY2007 · AI · contact PI
Induction of mucosal SIV immunity in non human primates by secreted Hsp-Gp96$229,313
R21 · FY2007 · AI · contact PI
Molecular Mechanisms of anti Tumor and anti Bacterial Cytotoxicity$222,845
R01 · FY2007 · CA · contact PI
Systemic and Mucosal HIV-Immunity by Hsp-Gp96 Vaccines$222,784
R21 · FY2007 · AI · contact PI
Administration Core$93,908
P01 · FY2007 · CA · contact PI
DR3 in Asthma and in Ontogeny$415,234
R01 · FY2006 · AI · contact PI
Molecular Mechanisms of anti Tumor and anti Bacterial Cytotoxicity$228,750
R01 · FY2006 · CA · contact PI
Systemic and Mucosal HIV-Immunity by Hsp-Gp96 Vaccines$228,626
R21 · FY2006 · AI · contact PI
DR3 in Asthma and in Ontogeny$419,767
R01 · FY2005 · AI
MOLECULAR MECHANISMS OF LYPHOCYTE MEDIATED TARGET LYSIS$297,755
R01 · FY2004 · CA
DR3 in Asthma and in Ontogeny$208,750
R01 · FY2004 · AI
MOLECULAR MECHANISMS OF LYPHOCYTE MEDIATED TARGET LYSIS$290,438
R01 · FY2003 · CA
Negative CTL Regulation for Tolerance Induction$227,250
R21 · FY2003 · AI
MOLECULAR MECHANISMS OF LYPHOCYTE MEDIATED TARGET LYSIS$283,337
R01 · FY2002 · CA
MOLECULAR MECHANISMS OF CD30+ LYMPHOMA GROWTH$215,529
R01 · FY2002 · CA
Negative CTL Regulation for Tolerance Induction$204,525
R21 · FY2002 · AI
MOLECULAR MECHANISMS OF LYPHOCYTE MEDIATED TARGET LYSIS$276,443
R01 · FY2001 · CA
Negative CTL Regulation for Tolerance Induction$227,250
R21 · FY2001 · AI
MOLECULAR MECHANISMS OF CD30+ LYMPHOMA GROWTH$210,527
R01 · FY2001 · CA
MOLECULAR MECHANISMS OF LYPHOCYTE MEDIATED TARGET LYSIS$269,612
R01 · FY2000 · CA
MOLECULAR MECHANISMS OF CD30+ LYMPHOMA GROWTH$205,668
R01 · FY2000 · CA